About RAINBOW
Company History
| 2019 Aug | Company established |
|---|---|
| 2019 Sep | Selected for Sapporo City’s Subsidy Program for Regenerative Medicine and Related Industries (NorthTec Foundation) |
| 2019 Sep | Certified as a venture company originating from Hokkaido University |
| 2019 Oct | Won Excellence Award, NEDO TCP Award, and Audience Award at No Maps NEDO Dream Pitch with Entrepreneur Expo |
| 2019 Dec | Won DNP Award and Ebara Corporation Award at the 2nd MedTech Grand Prix KOBE |
| 2020 Feb | Won Audience Award at NEDO-TCP 2019 |
| 2020 Feb | Won Best Award in Medical and Healthcare Category, and Mitsui Chemicals Future Society Award at MIRAI 2020 |
| 2020 Mar | Signed a joint research agreement with Hokkaido University (development of products for the practical application of BMSC cell therapy technology) |
| 2020 Jun | Selected for the Strategic Core Technology Advancement Program (supporting foundational technology) by the Ministry of Economy, Trade, and Industry, in collaboration with Terumo BCT and Hokkaido University |
| 2020 Jul | Transitioned to a company with a board of directors |
| 2022 Nov | Signed exclusive implementation right agreement with Mizuho Co., Ltd. for the company’s patent “Puncture Needle, Puncture Needle Kit, and Stereotactic Brain Surgery Device” in Japan |
| 2023 Oct | Selected for Go-Tech Program by the Ministry of Economy, Trade, and Industry, in collaboration with Terumo BCT and Hokkaido University |
| 2024 Jan | Signed a joint development agreement with Daicel Corporation and Daisen Membrane Systems Corporation for the development of cell product manufacturing technology |
| 2024 Mar | Selected for the Hokuyo Bank Startup Research and Development Fund |